National Coverage Analysis (NCA)

Levocarnitine for End Stage Renal Disease

CAG-00077N

Expand All | Collapse All

Contacts

Kim Long
Kimberly.long@cms.hhs.gov
410-786-5702
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Levocarnitine for End Stage Renal Disease CAG-00077N You are here